润达医疗：触发赎回条款，决定暂不提前赎回“润达转债”

Core Viewpoint - Shanghai RunDa Medical Technology Co., Ltd. has triggered the redemption clause for its convertible bonds due to stock price performance but has decided not to exercise this right at this time [1] Group 1: Redemption Clause Trigger - The company's stock has met the condition of closing prices being no less than 130% of the current conversion price for at least 15 out of 30 consecutive trading days from August 25 to September 17, 2025 [1] - The board of directors has decided not to exercise the early redemption right on September 17, 2025, and will also refrain from exercising this right for the next three months, from September 18 to December 17, 2025 [1] Group 2: Future Considerations - After December 17, 2025, if the redemption conditions are met again, the board will make a further decision regarding the redemption [1] - The relevant parties have not held the convertible bonds before the redemption conditions were met and have no plans to reduce their holdings in the next six months [1] Group 3: Convertible Bond Details - The "RunDa Convertible Bonds" were listed on July 13, 2020, with an initial conversion price of 13.36 yuan per share, which has been adjusted to 12.97 yuan per share [1]